中 文  |  English
 
  • Home
  • About us
    • About Viva
    • Company Culture
    • Management Team
    • Scientific Advisory Board
    • Investors and Board of Directors
    • Careers
  • Services
    • Service Overview
    • Gene–to-Protein & Gene–to-Structure
    • GPCR Targeted Discovery Programs
    • Fragment Based Lead Generation
    • High Level Medicinal Chemistry
    • In Vivo Models
    • In Vitro Pharmacology
    • Antibody Therapeutics Discovery
    • Protein Analysis
    • DMPK
  • News & events
    • What's New
    • In the News
    • Events
  • Project management
    • Log in
    • Contact CS manager
  • Contact us
    • Contact us
    • Online inquiry
  • What's New
  • In the News
  • Events
  • EBIS hosted a Networking event with Biotech Executives from China in Cambridge, MA, USA
  • EBIS (Expertise-based Integrated Services) presented at 6th international China pharmaceutical R&D Summit in Shanghai, China
  • Viva Biotech Ltd. presented at ChinaBio Leadership Retreat in Taicang, China
    home        News&events        What's New
What's New
  • Nov 07, 2011Viva Biotech Ltd. Appoints Dr. Sheldon Cao as Executive Director of Discovery Chemistry
  • Nov 07, 2011Viva Biotech Ltd. Appoints Dr. Xiaohong Liu as Vice President of In Vivo Pharmacology
  • Nov 07, 2011Viva Biotech Ltd. Appoints Dr. Kevin Qian as Senior Director of Structural Biology
  • Oct 15, 2011Viva Biotech Appoints Dr. Zengquan Wang as CBO & VP of Program Management
  • Sep 26, 2011Viva Passed the Ethical Audit by Intertek on Behalf of A Large Pharmaceutical Company with A High Score of 95
  • Jun 07, 2010Viva Biotech Ltd. Appoints Dr. Guyu Ho as Vice President of Business Development
     1 2 3     
网站制作:炙阳科技Copyright © 2008-2010 Viva Biotech Ltd. All Rights Reserved 沪ICP备09036683号